We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Simon Saxby Joins Board at Selcia


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Simon Saxby Joins Board at Selcia"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 

Simon Saxby is currently Vice-President Biologics of RecipharmCobra Biologics, a Swedish contract development and manufacturing company and has worldwide responsibility for the manufacturing of biologics.   Simon has over 25 years experience in the biotechnology industry, including several CEO positions, most recently at Cobra Biomanufacturing plc and Alpha Biologics.  He brings a blend of technical, business, sales and marketing skills and senior management, fund-raising and M&A experience.

Commenting on the appointment, Managing Director of Selcia, Dr Hans Fliri said: “I am delighted to welcome Simon to the management team.  Simon brings with him his considerable international experience, technical knowledge and commercial expertise.  We look forward to Simon helping us accelerate our UK and international market development plans”.

Advertisement